Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
12 Week	STARTED	Rivastigmine- Liquid Form	4
12 Week	STARTED	Liquid Placebo	4
12 Week	COMPLETED	Rivastigmine- Liquid Form	4
12 Week	COMPLETED	Liquid Placebo	4
12 Week	NOT COMPLETED	Rivastigmine- Liquid Form	0
12 Week	NOT COMPLETED	Liquid Placebo	0
20 Week	STARTED	Rivastigmine- Liquid Form	12
20 Week	STARTED	Liquid Placebo	11
20 Week	COMPLETED	Rivastigmine- Liquid Form	12
20 Week	COMPLETED	Liquid Placebo	10
20 Week	NOT COMPLETED	Rivastigmine- Liquid Form	0
20 Week	NOT COMPLETED	Liquid Placebo	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01084135/flow